You are subscribed to the Dermatology Times eNews.

Dermatology Times eNews

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

June 26, 2014

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

Arthritis drug spurs hair regrowth in alopecia patient

A Yale University dermatologist says the rheumatoid arthritis drug tofacitinib citrate allowed a patient with alopecia universalis to grow a full head of hair. » More

Share » facebook twitter LinkedIn Google+

ADVERTISEMENT

Current and emerging therapies for psoriatic arthritis
Symptoms of psoriatic arthritis include inflammation in the joints and excessive production of skin cells. Learn about treatment options to help reduce these symptoms in your patients. View our psoriatic arthritis topic-based resource center and Learn More.

FDA grants expanded use for Lymphoseek

Lymphoseek is now approved by the Food and Drug Administration to help clinicians determine whether squamous cell carcinoma has spread to a patient’s head and neck region. » More

Share » facebook twitter LinkedIn Google+

fyi...

80%

 

Increase in risk of melanoma in patients who had at least 5 sunburns from ages 15-20

Source: Cancer Epidemiology, Biomarkers & Prevention

ADVERTISEMENT

Botulinum toxin injections: Cosmetic & Therapeutic treatment options
Botulinum toxin have a variety of medical uses, including smoothing out frown lines and treating pain. Video, articles, tools and CME to help you stay up-to-date on the latest medical advances involving neurotoxins. Learn More.

The skin and pregnancy: Physiological changes and dermatoses

The hormonal and physical milieu of pregnancy precipitates many cutaneous skin changes, among them pigmentation and vascularity. All are considered normal during pregnancy and yet evoke significant patient anxiety. Clinicians review common skin changes and dermatoses of pregnancy. » More

Share » facebook twitter LinkedIn Google+

FDA approves new drug for skin infections

The Food and Drug Administration has approved Sivextro (tedizolid phosphate, Cubist Pharmaceuticals) for the treatment of acute skin infections. » More

Share » facebook twitter LinkedIn Google+

RELATED COVERAGE

Researchers reconsider acne development process

The use of microsponges in dandruff shampoos

Poor differentiation, MTS spark concerns with sebaceous carcinoma

New Job Opportunities

AZ •Alliance Dermatology & MOHS Center

CA •Integrated Dermatology

CO •Integrated Dermatology

CO •Integrated Dermatology

District of Columbia •Integrated Dermatology

FL •Betty Bellman, MD PA

FL •Integrated Dermatology

IL •Southwest Dermatology

MI •Ann Arbor Dermatology

NC •Integrated Dermatology

NJ •David A High, MD

New Job Opportunities

NJ •Company Confidential

NY •Aristocrat Plastic Surgery

NY •Company Confidential

NY •Company Confidential

NY •Queens Crossing Dermatology

NY •Philip Bruder MD

NY •Company Confidential

NV •Integrated Dermatology

OR •Cynthia Dreyer MD

VA •Integrated Dermatology

VT •Dorset Street Dermatology

WI •Gundersen Lutheran Health System

WI •Mayo Clinic Health System

 
Powered by Modern Medicine Advanstar Medical Communications Group